Skip to content
10-Q

Quarterly Report

Translate Bio, Inc.

0001193125-20-211886

← back to feed
Filed
Aug 6, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Aug 3, 2020 74.24M sh
Short Term Investments Q2 2020 · Jun 30, 2020 $20.03M
Short Term Investments Q2 2020 · Dec 31, 2019 $104.1M
Current Liabilities Q2 2020 · Jun 30, 2020 $51.77M
Current Liabilities Q2 2020 · Dec 31, 2019 $41.67M
Total Liabilities Q2 2020 · Jun 30, 2020 $182.89M
Total Liabilities Q2 2020 · Dec 31, 2019 $182.67M
Current Assets Q2 2020 · Jun 30, 2020 $316.22M
Current Assets Q2 2020 · Dec 31, 2019 $203.62M
Total Assets Q2 2020 · Jun 30, 2020 $454.28M
Total Assets Q2 2020 · Dec 31, 2019 $336.2M
Cash And Equivalents Q2 2020 · Dec 31, 2019 $84.58M
Cash And Equivalents Q2 2020 · Jun 30, 2019 $74.9M
Capex Q2 2020 · Jun 30, 2019 $1.79M
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$41.45M
Stockholders Equity Q2 2020 · Jun 30, 2019 $115.7M
Stockholders Equity Q2 2020 · Mar 31, 2019 $95.11M
Stockholders Equity Q2 2020 · Dec 31, 2018 $125.3M
Sga Expense Q2 2020 · Jun 30, 2019 $7.85M
Sga Expense Q2 2020 · Jun 30, 2019 $14.4M
Rd Expense Q2 2020 · Jun 30, 2019 $16.63M
Rd Expense Q2 2020 · Jun 30, 2019 $34.05M
Net Income Q2 2020 · Jun 30, 2019 −$27.83M
Net Income Q2 2020 · Jun 30, 2019 −$61.03M
Net Income Q2 2020 · Mar 31, 2019 −$33.2M
Operating Income Q2 2020 · Jun 30, 2019 −$28.19M
Operating Income Q2 2020 · Jun 30, 2019 −$62.39M
Revenue Q2 2020 · Jun 30, 2019 $1.17M
Revenue Q2 2020 · Jun 30, 2019 $2.65M